Cargando…
To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission
Autores principales: | Sevindik, Omur Gokmen, Mergen, Mahmut, Mergen, Sena, Mutlu, Yasa Gul, Aydın, Berrin Balık, Serin, Istemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361949/ https://www.ncbi.nlm.nih.gov/pubmed/35906348 http://dx.doi.org/10.1007/s00277-022-04938-0 |
Ejemplares similares
-
First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS)
por: Sevindik, Omur Gokmen, et al.
Publicado: (2022) -
Persistent Polyclonal B-Cell Lymphocytosis with Binucleated Lymphocytes
por: Balık Aydın, Berrin, et al.
Publicado: (2021) -
Should Core Needle Lymph Node Biopsy be a Relevant Alternative to Surgical Excisional Biopsy in Diagnostic Work Up of Lymphomas?
por: Gül Mutlu, Yaşa, et al.
Publicado: (2023) -
Melanoma: BRAFi Rechallenge
por: Kosmidis, Christoforos S., et al.
Publicado: (2023) -
Current Status in Rechallenge of Immunotherapy
por: Hu, Han, et al.
Publicado: (2023)